Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02652052 · ClinicalTrials.gov registry record · Phase 1
Hematopoietic Stem Cell Transplant Survivors Study
A Phase 1 study of Stem Cell Transplant, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT02652052: Completed Phase 1 study of Stem Cell Transplant, sponsored by Mayo Clinic.
NCT02652052 is a Phase 1 study of Stem Cell Transplant that has completed, run by Mayo Clinic. The registered enrollment target is 9 participants, below the 195-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02652052, a Phase 1 study of Stem Cell Transplant, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hope to find the proof of principle concept from this pilot study so that the investigators can design a clinical trial based on the results of the explanatory hypothesis.
Primary Outcome
Evaluate the association of frailty with measures of senescence in HSCT survivors - level of frailty as assessed by FRIED
Conditions Studied
Interventions
- OTHER Standard of Care - Observation Only
- DRUG Group 2: Quercetin
- DRUG Group 2: Dasatinib
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2023-05-23 |
| Phase | Phase 1 |
What the finished NCT02652052 record still lists
NCT02652052 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 195-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Stem Cell Transplant appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care - Observation Only is the first listed.
NCT02652052 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02652052 about?
NCT02652052 is a clinical study titled "Hematopoietic Stem Cell Transplant Survivors Study". The investigators hope to find the proof of principle concept from this pilot study so that the investigators can design a clinical trial based on the results of the explanatory hypothesis.
What is the current status of trial NCT02652052?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2016-03-01. Estimated completion is 2023-05-23.
What conditions does trial NCT02652052 study?
This clinical trial studies the following conditions: Stem Cell Transplant.
What interventions are being tested in trial NCT02652052?
The interventions under investigation include: Standard of Care - Observation Only (OTHER), Group 2: Quercetin (DRUG), Group 2: Dasatinib (DRUG).
Who is sponsoring clinical trial NCT02652052?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02652052 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02652052's enrollment target sits among peer trials
9 10th of 9 the lowest of 9 other Stem Cell Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stem Cell Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
RECRUITING · NA
-
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
RECRUITING · NA
-
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
RECRUITING · NA
-
Shingrix In Recipients of Allogeneic Transplants
RECRUITING · Phase 2
-
BMT4me: Post-HSCT Medication Adherence mHealth App
RECRUITING · NA
-
Mosaic Trial for Stem Cell Transplant Recipients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI